Erythropoietin as a Neuroprotective Agent

Neonatal Network

Volumn 30, Issue 2, 2011, Pages 135-139

  Givens Bell, Susan ^a,b  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; NEUROPROTECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BRAIN; DRUG EFFECT; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEWBORN; PHYSIOLOGY;

BRAIN; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS;

EID: 79960995184     PISSN: 07300832     EISSN: 15392880     Source Type: Journal    
DOI: 10.1891/0730-0832.30.2.135     Document Type: Article

References (27)

1. Brines M. L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N. C.,. Cerami A., (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences of the United States of America, 97 (19), 10526-10531. doi:10.1073/pnas.97.19.10526
2. Demers E. J., McPherson R. J., & Juul S. E., (2005). Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatric Research, 58 (2), 297-301. doi:10.1203/01.PDR.0000169971.64558.5A
3. Zhu C., Kang W., Xu F., Cheng X., Zhang Z., Jia L.,., Wang X., (2009). Erythropoietin improved neurological outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics, 124 (2), e218-e226. doi:10.1542/peds.2008-3553
4. Chang Y. S., Mu D., Wendland M., Sheldon R. A., Vexler Z. S., Mcquillen P. S., & Ferriero D. M., (2005). Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatric Research, 58 (1), 106-111. doi:10.1203/01.PDR.0000163616.89767.69
5. Bierer R., Peceny M. C., Hartenberger C. H., & Ohls R. K., (2006). Erythropoietin and neurodevelopmental outcome in preterm infants. Pediatrics, 118 (3), e635-e640. doi:10.1542/peds.2005-3186
6. Marti H. H., (2004). Erythropoietin and the hypoxic brain. The Journal of Experimental Biology, 207, 3233-3242. doi:10.1242/jeb.01049
7. Kuratowska Z., Lewartowski B., & Michalak E., (1961). Studies on the production of erythropoietin by isolated perfused organs. Blood, 18, 527-534.
8. Koury S. T., Bondurant M. C., Koury M. J., & Semenza G. L., (1991). Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood, 77 (11), 2497-2503.
9. Zanjani E. D., Poster J., Burlington H., Mann L. I., & Wasserman L. R., (1977). Liver as the primary site of erythropoietin production in the fetus. The Journal of Laboratory and Clinical Medicine, 89 (3), 640-644.
10. Krantz S. B., (1991). Erythropoietin. Blood, 77, 419-434.
11. Tan C. C., Eckardt K.-U., Firth J. D., & Ratcliffe P. J., (1992). Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. American Journal of Physiology, 263, F474-F481.
12. Baciu I., Oprişiu C., Derevenco P., Vasile V., Mureşan A., Hriscu M., & Chiş I., (2000). The brain and other sites of erythropoietin production. [Abstract]. Romanian Journal of Physiology: Physiological Sciences, 37 (1-4), 3-14.
13. Dame C., Juul S. E., & Christensen R. D., (2001). The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate, 79 (3-4), 228-235.
14. Shingo T., Sorokan T., Shimaszaki S. T., & Weiss S., (2001). Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cell. Journal of Neuroscience, 21 (24), 9733-9743.
15. Sakanaka M., Wen T. C., Matsuda S., Masuda S., Morishita E., Nagao M., & Sasaki R., (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proceedings of the National Academy of Sciences of the United States of America, 95 (8), 4635-4640. doi:10.1073/pnas.95.8.4635
16. Assandri R., Egger M., Gassmann M., Niggli E., Bauer C., Forster I., & Görlach A., (1999). Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. The Journal of Physiology, 516 (Pt. 2), 343-352. doi:10.1111/j.1469-7793.1999.0343v.x
17. Yamamoto M., Koshimura K., Kawaguchi M., Sohmiya M., Murakami Y., & Kato Y., (2000). Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice. Neuroscience Letters, 292 (2), 131-133. doi:10.1016/S0304-3940(00)01441-5
18. Yamaji R., Okada T., Moriya M., Naito M., Tsuruo T., Miyatake K., & Nakano Y., (1996). Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. European Journal of Biochemistry, 239 (2), 494-500. doi:10.1111/j.1432-1033.1996.0494u.x
19. Sugawa M., Sakurai Y., Ishikawa-Ieda Y., Suzuki H., & Ason H., (2002). Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neuroscience Research, 44 (4), 391-403. doi:10.1016/S0168-0102(02)00161-X
20. Dirnagl U., Simon R. P., & Hallenbeck J. M., (2003). Ischemic tolerance and endogenous neuroprotection. Trends in Neurosciences, 26 (5), 248-254.
21. Marti H. H., Bernaudin M., Petit E., & Bauer C., (2000). Neuroprotection and angiogenesis: A dual role of erythropoietin in brain ischemia. News in Physiological Sciences, 15, 225-229.
22. National Institutes of Health. (n.d.). List result for erythropoietin in neonates. Retrieved from http://clinicaltrials.gov/ct2/results?term= erythropoietin+in+neonates&map=AF
23. Elmahdy H., El-Mashad A.-R., El-Bahrawy H., El-Gohary T., El-Barbary A., & Aly H., (2010). Human recombinant erythropoietin in asphyxia neonatorum: Pilot trial. Pediatrics, 125 (5), e1135-e1142. doi:10.1542/peds.2009-2268
24. Kumar A., Mittal R., Khanna H. D., & Basu S., (2008). Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics, 122 (3), e722-e727. doi:10.1542/peds.2008-0269
25. Sarnat H. B., & Sarnat M. S., (1976). Neonatal encephalopathy following fetal distress: A clinical and electroencephalographic study. Archives of Neurology, 33 (10), 696-705.
26. Jacobs S. E., Hunt R., Tarnow-Mordi W. O., Inder T. E., & Davis P. G., (2007). Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews, 4, CD003311. doi:10.1002/14651858.CD003311.pub2
27. Thompson C. M., Puterman A. S., Linley L. L., Hann F. M., van der Elst C. W., Molteno C. D., & Malan A. F., (1997). The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatrica, 86 (7), 757-761. doi:10.1111/j.1651-2227.1997.tb08581.x